Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...

Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...

Basophilia at diagnosis of myeloproliferative neoplasms was associated with a more aggressive disease phenotype and poorer ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

A desperate mum has come forward saying that ‘cancer isn’t all about chemo’ and praises a special diet that she believes ...

With Teddy now having a 97% probability of cure, Sarah wants to help others with her new book, which has been praised by ...

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Chronic lymphocytic leukemia (CLL) is a mature B-cell hematological malignancy characterized by progressive clonal proliferation of B lymphocytes in the peripheral blood, bone marrow, and lymph nodes.

The partnership will address the backlog of BMT patients, aiming to provide timely access to critical procedures.

As part of this initiative, researchers at Hospital for Special Surgery in New York City are beginning a clinical trial to investigate whether concentrated bone marrow aspirate (cBMA) can improve ...